Authors

  1. Cummings, K. Michael PhD, MPH

Article Content

The 6 tobacco-related articles in this issue of JPHMP will remind readers of both the tremendous progress that has been made over the past half century in reducing cigarette use and the continuing challenges that remain to be addressed to accelerate a decline in the health consequences of cigarette smoking.1-6 The 1964 report of the Surgeon General's Advisory Committee marked the beginning of a sea change in public attitudes about smoking that have continued to evolve up to this day.7 For those of us who are old enough to remember that there was a time when smoking was permitted nearly everywhere: smokers could light up at work, in hospitals, in school buildings, in bars, in restaurants, and even on buses, trains, and planes. It was common to see doctors, athletes, and celebrities smoking and advertising cigarettes. So common was cigarette advertising that a 1967 Federal Trade Commission report observed that it was "impossible for Americans of almost any age to avoid cigarette advertising."8

 

How things have changed. Once a sign of class and glamour, smoking is no longer sexy, cool, or even normal. The shift in public perceptions is important because perception and the social pressure that comes along with it have been the driving force behind the decline of smoking over the last half century. Once considered a rite of passage into adulthood, the majority of teenagers today have never smoked and do not intend to. In 1965, 42% of adults were current smokers while the latest figures from the Centers for Disease Control and Prevention show smoking rates having fallen to 15%.9,10

 

While the success of comprehensive tobacco control policies and programming is now irrefutable,11,12 the article by Roeseler and colleagues1 documents that the implementation of evidence-based tobacco control policies and programs is suboptimal in all states, with huge variations across states and regions. The good news is that many states are making slow and steady progress in implementing smoke-free policies, hiking cigarette taxes, and adopting policies to discourage smoking by young people.

 

The article by Neuberger and LeClair2 provides yet another demonstration that the public is way out ahead of the policy makers when it comes to tobacco control.13 In 2010, Kansas legislators passed the Kansas Clean Indoor Air Act that effectively banned smoking in indoor workplaces and public spaces, restaurants, and bars. Opponents of the law challenged its enforceability and public support, but the evidence presented in this article shows that compliance with the law was outstanding with few violations of the law reported (ie, 1.47 per 100 000), and only a handful of fines or sanctions issued over a 2-year period. As the authors note in their conclusion, "if a socially conservative state such as Kansas with a keen interest in individual liberties can create, observe, and maintain such a law, the other 26 states without such a law (or the United States as a whole) could surely do the same."2

 

The article by Mamudu and colleagues3 describes some of the challenges associated with implementing another type of tobacco-free policy-that is, tobacco-free campuses. Tobacco-free campuses' policies represent an effort to extend tobacco-free elementary and secondary school policies to young adults, who often gravitate toward cigarette smoking when they get to college. College campuses have always been a hotbed of tobacco marketing activity for manufacturers who recognize if they fail to get someone smoking by 25 years of age, chances are they will never take up smoking.14 So far, about 15% of US colleges/universities have implemented tobacco-free campus policies and more are likely to join this movement as the appeal of smoking continues to wane among young people.3 Tobacco-free campus policies will also likely become easier to implement as more states and localities increase the legal age for the purchase of tobacco from 18 to 21 years, as recently recommended by the Institute of Medicine.15,16

 

While addressing tobacco use by college students may become easier over time, a more challenging problem facing tobacco control is how to address tobacco use among the poor and disenfranchised segments of society. More than 25% of people living below the poverty line smoke, and smoking is more common among those with mental health and substance abuse diagnoses.17,18 Stress due to economic insecurity and social and medical problems can not only lead people into smoking but can also make it harder to quit.19 Making matters worse, cigarette companies often target low-income neighborhoods with their advertising and price promotions to ensure a steady stream of customers.14,20

 

The article by Xu et al4 describes consumers' participation in some of the price marketing schemes that cigarette makers have devised to keep people smoking. What is apparent from the findings of this study is that cigarette companies have employed a wide array of sophisticated price marketing strategies to appeal to different segments of the smoking market. Persuading government officials to adopt policies that keep cigarette prices high and reduce price differentials among brands would prevent smoking initiation and encourage more smokers to quit.21 Not surprisingly, tobacco companies fight the hardest when it comes to policies that threaten to increase the purchase price of their products, which is justification enough for public health officials to keep pushing for ways to raise tobacco prices whether it be through excise taxes, minimum pricing laws, improved track and tracing methods to prevent tax evasion, and/or policies that prohibit price promotions such as couponing and promotional allowances to retailers and wholesalers.22,23

 

While much progress has been made in reducing smoking in Americans, a careful analysis of what has been driving down smoking prevalence rates over the past 20 years reveals that much of the decline is the result of fewer young people taking up smoking, not so much the outflow of adult smokers quitting and remaining smoke-free.23 The reason for this is obvious but still not very well appreciated; nicotine addiction is hard to overcome.19 It is important to recognize that the cigarette manufacturers have worked hard to engineer their cigarettes in ways that make them difficult for people to stop using.19,23-26 The article by Dube and colleagues5 reinforces what tobacco companies have known for decades ago, most adult smokers would quit if they could.27 The problem as Dube et al5 point out is that the current array of tobacco cessation treatments are poor substitutes for cigarettes, since they are costly and inconvenient to acquire and use.

 

While we have had clinical practice guidelines for treating nicotine addiction for over a decade, the guidelines have never been fully translated into practice.28,29 The sad reality is that the treatment of nicotine addiction is severely underresourced, which is why tobacco cessation treatment interventions have had relatively little impact on reducing smoking prevalence rates. Policies do matter. The article by Athar and colleagues6 provides an analysis of what would happen if states were to adopt policies to expand Medicaid, the coverage, and delivery of nicotine replacement therapies to smokers. The results are predictable, make it easier for smokers to get treatment of their nicotine addiction, smoking rates will go down, and the states and taxpayers will realize a net cost savings by reducing medical expenditures from treating costly smoking-related diseases.6

 

Fiscal conservatives should embrace smoking cessation since there are relatively few clinical interventions that are comparable in terms of cost-effectiveness and that offer the potential to stem skyrocketing health care costs. Unfortunately, most states today would get an "F-grade" when it comes to delivering tobacco cessation support to smokers.30 Unfortunately, the US health system is set up to reward the treatment of acute health problems and not prevent problems from happening in the first place. Even in places where reimbursement barriers for smoking cessation have been theoretically been eliminated, getting smoking cessation treatments reimbursed is often difficult. Not surprisingly, many patients and clinicians simply give up. The tobacco control movement needs to do better job advocating for policies that will make it easier for smokers to get effective treatments (both pharmacologic and behavioral) to help them overcome their nicotine addiction. Here are a few suggestions of what might be done:

  

1. Eliminate where possible the bureaucratic barriers that impede the delivery (eg, prior authorizations and copays) and delay reimbursement of smoking cessation treatments provided in health care settings.

 

2. Incentivize health care institutions to do a much better job delivering tobacco cessation support to their patients. For example, as a condition of receiving a license to operate, hospitals should be required to offer evidence-based tobacco cessation treatment to all smokers as the Joint Commission recommended in 2012.31 Smokers, of course, would be free to opt out of treatment, but evidence shows that most will happily accept treatment if provided.

 

3. Promote policies that improve the training of clinicians in how to effectively treat nicotine addiction. Clinicians of all disciplines need to have a better understanding of nicotine addiction, as many still approach cigarette addiction as a character flaw rather than as a medical condition that requires treatment. Tobacco and nicotine addiction and treatment need to be consistently taught in medical schools, nursing schools, and other ancillary schools. Questions about tobacco and nicotine dependence and treatment need to be included in certification examinations.

 

4. Promote policies that encourage companies to develop and market cost-competitive evidence-based harm reduction substitutes for cigarettes.

 

5. Stop corporate welfare for tobacco companies, allowing them to collect the profits from selling cigarettes while passing off the downstream health care costs of treating nicotine addiction and the associated diseases onto taxpayers. Raising tobacco taxes to a level that reimburses states for their health care expenses and earmarking funds to cover the costs of smoking cessation services would be a start.1

 

6. Finally, it is well past time for the cigarette industry be held accountable for the consequences of manufacturing and promoting a product that causes so much disease and death. State and federal laws that have shielded cigarette manufacturers from liability for selling defective products need to be changed.32

 

In summary, the tobacco-related articles in this issue of Journal of Public Health Management and Practice remind us that the decline in smoking prevalence that has taken place over the past 50 years has come about not only just because of greater public understanding of the health risks of tobacco but also because cigarette smoking is simply increasingly less socially accepted as it once was and that public health efforts to control tobacco in the future need to keep it that way.

 

REFERENCES

 

1. Roeseler A, Solomon M, Beatty C, Sipler AM. The tobacco control network's policy readiness and stage of change assessment: what the results suggest for moving tobacco control efforts forward at the state and territorial levels. J Public Health Manage Pract. 2016;22(1):9-19. [Context Link]

 

2. Neuberger JS, LaClair B. Implementation of clean indoor air laws: complaints, citations, and fines or sanctions related to possible violations of the Kansas Clean Indoor Air Act. J Public Health Manage Pract. 2016;22(1):57-64. [Context Link]

 

3. Mamudu HM, Veeranki SP, David KM, Boghozian RK, Littleton MA. Exploring support for 100% college tobacco-free policies and tobacco-free campuses among college tobacco users. J Public Health Manage Pract. 2016;22(1):29-39. [Context Link]

 

4. Xu X, Wang X, Caraballo RS. Is every smoker interested in price promotions? An evaluation of price-related discounts by cigarette brands. J Public Health Manage Pract. 2016;22(1):20-28. [Context Link]

 

5. Dube SR, Pesko M, Xu X. A cross-sectional examination of what smokers' perceive to be important and their willingness to pay for tobacco cessation medications. J Public Health Manage Pract. 2016;22(1):48-56. [Context Link]

 

6. Athar HM, Chen ZA, Contreary K, Xu X, Dube SR, Chang MH. Impact of increasing coverage for selected smoking cessation therapies with no out-of-pocket cost among the Medicaid population in Alabama, Georgia, and Maine. J Public Health Manage Pract. 2016;22(1):40-47. [Context Link]

 

7. Cummings KM, Proctor RN. The changing public image of smoking in the United States: 1964-2014. Cancer Epidemiol Biomark Prev. 2014;23(1):32-36. [Context Link]

 

8. Federal Trade Commission. Report to Congress Pursuant to the Federal Cigarette Labeling and Advertising Act. Washington, DC: United States Federal Trade Commission; 1967. [Context Link]

 

9. Giovino GA, Schooley MW, Zhu BP, et al. Surveillance for selected tobacco-use behaviors-United States, 1900-1994. Centers for Disease Control and Prevention. CDC. MMWR Surveill Summ. 1994;43(No. SS-3):1-50. [Context Link]

 

10. Clarke TC, Ward BW, Freeman G, Schiller JS. Early release of selected estimates based on data from the January-March 2015 National Health Interview Survey. National Center for Health Statistics. September 2015. http://www.cdc.gov/nchs/nhis.htm. [Context Link]

 

11. The Guide to Community Preventive Services. Reducing tobacco use and secondhand smoke exposure: comprehensive tobacco control programs. http://www.thecommunityguide.org/tobacco/comprehensive.html. Published 2014. Accessed January 1, 2015. [Context Link]

 

12. Centers for Disease Control and Prevention. Best Practices for Comprehensive Tobacco Control Programs-2014. Atlanta: U.S. Department of Health and Human Services, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. [Context Link]

 

13. Hyland A, Cummings KM. Compliance with the New York City Smoke-free Air Act. J Public Health Manage Pract. 1999;5(1):43-52. [Context Link]

 

14. National Cancer Institute. The Role of the Media in Promoting and Reducing Tobacco Use. Tobacco Control Monograph No. 19. Bethesda, MD: U.S. Department of Health & Human Services, National Institutes of Health, National Cancer Institute; 2008:11. NIH Pub. No. 07-6242. [Context Link]

 

15. Schneider SK, Buka SL, Winickoff JP, O'Donnell L. Community reductions in youth smoking after raising the minimum tobacco sales age to 21 [published online ahead of print June 12, 2015]. Tob Control. doi:10.1136/tobaccocontrol-2014-052207. [Context Link]

 

16. Institute of Medicine. Public Health Implications of Raising the Minimum Age of Legal Access to Tobacco Products. Washington, DC: The National Academies Press; 2015. [Context Link]

 

17. Centers for Disease Control and Prevention. Current cigarette smoking among adults-United States, 2005-2013. MMWR Morb Mortal Wkly Rep. 2014;63(47):1108-1112. [Context Link]

 

18. Gfroerer J, Dube SR, King BA, Garrett BE, Babb S, McAfee T. Vital signs: current cigarette smoking among adults aged >18 years with mental illness-United States, 2009-2011. MWWR Morb Mortal Wkly Rep. 2013;62:81-87. [Context Link]

 

19. U.S. Department of Health & Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health & Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2010. [Context Link]

 

20. Brown-Johnson CG, England LJ, Ling PM. Tobacco industry marketing to low socioeconomic status women in the USA. Tob Control. 2014;23:e139-e146. [Context Link]

 

21. Chaloupka FJ, Straif K, Leon ME. Effectiveness of tax and price policies in tobacco control. Tob Control. 2011;20:235-238. [Context Link]

 

22. Golden SD, Smith MH, Feighery EC, Roesler A, Rogers T, Ribisl KM. Beyond excise taxes: a systematic review of literature on non-tax policy approaches to raising tobacco product prices. Tob Control. doi:10.1136/tobaccocontrol-2015-052294. [Context Link]

 

23. US Department of Health & Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. [Context Link]

 

24. Hurt RD, Robertson CR. Prying open the door to the tobacco industry's secrets about nicotine: the Minnesota Tobacco Trial. JAMA. 1998;280(13):1173-1181. [Context Link]

 

25. Stevenson T, Proctor RN. The secret and soul of Marlboro: Phillip Morris and the origins, spread, and denial of nicotine freebasing. Am J Public Health. 2008;98(7):1184-1194. [Context Link]

 

26. Cummings KM. Is it not time to reveal the secret sauce of nicotine addiction? Tob Control. 2015;24:420-421. [Context Link]

 

27. Teague CE Jr Memo to: Dr. GR DiMarco Re: Nordine Study. December 1, 1982. Bates: 500898255-500898257. [Context Link]

 

28. Fiore MC. A clinical practice guideline for treating tobacco use and dependence: a US Public Health Service report. JAMA. 2000;283;(24):3244-3254. [Context Link]

 

29. Fiore MC. A clinical practice guideline for treating tobacco use and dependence: 2008 update. Am J Public Health. 2008;35(2):158-176. [Context Link]

 

30. American Lung Association. State of tobacco control. http://www.stateoftobaccocontrol.org/at-a-glance/. Published 2015. Accessed October 16, 2015. [Context Link]

 

31. Fiore MC, Goplerud E, Schroeder SA. The Joint Commission's new tobacco-cessation measures-will hospitals do the right thing? N Engl J Med. 2012;366:1172-1174.

 

32. Cummings KM, Gustafson JW Jr, Sales DJ, Khuri FR, Warren GW. Business as usual is not acceptable. Cancer. 2015;121(17):2864-2865.